IOVA ▼ -2.6% - Iovance Biotherapeutics, Inc.
$IOVA - Iovance Presents New Data at ESMO 2026 Demonstrating Deep, Durable Responses with Lifileucel TIL Cell Therapy Plus Pembrolizumab in Frontline Advanced Melanoma
23-OCT-2026 10:15 AM ET
Share this post
More filings for $IOVA
IOVA ▼ -5.6% - Iovance Biotherapeutics, Inc.Nov 12, 2026IOVA - Iovance Biotherapeutics, Inc. - SEC Filing Update (10-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 10, 2026IOVA ▲ +3.8% - Iovance Biotherapeutics, Inc.Nov 5, 2026IOVA ▲ +5.3% - Iovance Biotherapeutics, Inc.Nov 5, 2026IOVA ▼ -9.2% - Iovance Biotherapeutics, Inc.Oct 29, 2026IOVA ▲ +13.2% - Iovance Biotherapeutics, Inc.Oct 28, 2026
View full $IOVA filing history →💬 Comments
Loading comments…
Leave a comment